Skip to main content
. 2018 Apr 5;9(2):13–19.

Table 1.

Clinical and laboratory characteristics of CHB patients and normal controls

CHB without steatosis N = 27 CHB with steatosis N = 19 Normal controls N = 23 P value

Mean (SD) Mean (SD) Mean (SD)
Age 41.7 (13.1) 47.5 (11.3) 28.7 (8.6) <0.001
BMI (kg/m2) 25.1 (5.7) 26.4 (3.9) 22.0 (1.8) 0.005
FBS (mg/dl) 90.9 (11.4) 106.1 (28.9) 86.9 (9.2) 0.002
Cholesterol (mg/dl) 201.9 (46.0) 206.1 (38.4) 200.0 (41.5) NS
Triglycerides (mg/dl) 108.8 (62.6) 134.9 (45.3) 68.9 (41.5) <0.001
HDL-C (mg/dl) 49.5 (17.2) 37.5 (9.3) 60.0 (17.8) <0.001
LDL-C (mg/dl) 124.2 (37.5) 138.1 (34.2) 121.5 (35.0) NS
VLDL-C (mg/dl) 21.6 (12.6) 26.9 (9.0) 13.9 (8.3) 0.001
Non-HDL-C (mg/dl) 152.3 (46.4) 168.6 (39.6) 140.0 (41.3) NS
AST (IU/L) 42.2 (46.9) 46.4 (34.5) 21.2 (8.5) 0.054
ALT (IU/L) 83.6 (126.3) 75.4 (43.9) 42.3 (15.0) NS

Abbreviations: BMI, body mass index; FBS, fasting blood sugar; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; VLDL-C, very low density lipoprotein; Non-HDL-C, non-high density lipoprotein cholesterol (total cholesterol minus HDL-C); AST, aspartate transaminase; ALT, alanine transaminase; IL28B, interleukin 28B; SD, standard deviation; NS, not significant.